MedPath

Effect of nagaradi kwath aschyotan in kaphaj abhishyanda(acute mucopurulent conjunctivitis)

Phase 2
Conditions
Health Condition 1: H100- Mucopurulent conjunctivitis
Registration Number
CTRI/2024/08/072101
Lead Sponsor
Dr Chetan narayan gotad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patients with classical signs and symptoms of kaphaj abhishyanda.

2. age group of 18 to 50 years.

3. patients willing to participate with consent

Exclusion Criteria

1.patient below the age of 18 and above 50 yrs of age.

2. patient with Corneal ulcers,Kerato conjunctivitis

Kraumatic occular injuries complicated Dacryocystitis Diabeties myelitis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in signs and symptoms of kaphaj abhishyand after application of nagaradi kwath aschyotan.Timepoint: 7 days
Secondary Outcome Measures
NameTimeMethod
where the trial group stands in comparison with control group in reduction with signs <br/ ><br>and symptoms of kaphaj abhishyanda.Timepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath